9/22/2020 12:30 PM
The shares of Illumina, Inc. (NASDAQ: ILMN) are down 1.6% at $265.72 at last check, after J.P. Morgan Securities downgraded the biotechnology company to "neutral" from "overweight," and both Stifel a...
7/12/2019 10:28 AM
Biopharma concern Illumina, Inc. (NASDAQ:ILMN) is eyeing its worst day in nearly three years, after the company reported preliminary second-quarter revenue that fell well below analysts' expectations...
9/19/2018 11:45 AM
Healthcare stocks Align Technology, Inc. (NASDAQ:ALGN), Illumina, Inc. (NASDAQ:ILMN), and Eli Lilly And Co (NYSE:LLY) have put in tremendous technical performances this year, with all three trading...
1/9/2018 2:58 PM
The U.S. stock market is scaling record highs once again, as bank stocks surge ahead of the start of earnings season. A rally in healthcare shares is also lifting the broader equities indexes, with s...
5/30/2017 11:00 AM
If recent history is any indicator, bullish stock and options traders may want to consider a pair of biotechs before June kicks off on Thursday. According to data from Schaeffer's Senior Quantitative...